VYOME HOLDINGS, INC. Deferred Tax Assets, Tax Credit Carryforwards
VYOME HOLDINGS, INC. (HIND) had Deferred Tax Assets, Tax Credit Carryforwards of $5.49 million as of 2019-12-31, per its 10-K filed 2021-03-12.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxCreditCarryforwards · last filed 2021-03-12
- 2019-12-31: Deferred Tax Assets, Tax Credit Carryforwards $5.49M.
- 2018-12-31: Deferred Tax Assets, Tax Credit Carryforwards $4.90M.
- 2017-12-31: Deferred Tax Assets, Tax Credit Carryforwards $3.75M.
- 2016-12-31: Deferred Tax Assets, Tax Credit Carryforwards $2.77M.
| Period end | Deferred Tax Assets, Tax Credit Carryforwards |
|---|---|
| 2019-12-31 | $5.49M 10-K · filed 2021-03-12 |
| 2018-12-31 | $4.90M 10-K · filed 2020-02-27 |
| 2017-12-31 | $3.75M 10-K · filed 2019-02-22 |
| 2016-12-31 | $2.77M 10-K · filed 2018-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |